PARK8 (LRRK2) Antibody (L229) Blocking peptide
PARK8 (LRRK2) Antibody (L229) Blocking peptide
Product Specifications
Product Name Alternative
Leucine-rich repeat serine/threonine-protein kinase 2, Dardarin, LRRK2, PARK8
UniProt
Q5S007
Field of Research
Cell Biology
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the LRRK2 region of human PARK8 (LRRK2) . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940525-100 1x 100 µL
CD63 (MX-49.129.5), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741003-100 1x 100 µL
Mucin 5AC (MUC5AC) (58M1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471236-100 1x 100 µL
PTH (Parathyroid Hormone) (N & C Terminal) (3H9 + PTH/1175), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040527-100 1x 100 µL
Nucleolin (364-5), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details